Skip to main content
Log in

Differential expression of the androgen receptor gene is correlated with CAG polymorphic repeats in patients with prostate cancer

  • Research Article
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

Prostate cancer (PCa) is one of the most common types of cancer in men. The aetiology of the disease is not well established, but it has been related to one of the main pathways of regulation of prostate proliferation, mediated by androgens. The androgen receptor (AR) gene encodes the androgen-receptor protein, which functions as a transactivation factor for steroid hormones. It has been proposed that the AR gene transcription levels are mediated by short tandem repeats corresponding to the CAG sequence. However, there are conflicting results in this relationship. We evaluated the expression levels of the AR gene and identified the number of CAG repeats (CAGn) in the Mexican population, establishing the relationship between expression levels and increase in the number of CAG repeats. We evaluated the expression levels of AR in tissue samples of PCa and benign prostate disease, such as benign prostatic hyperplasia, or prostatitis, to determine the difference in their expression levels. Our results showed a statistically insignificant underexpression of 0.64-fold decrease in AR levels of PCa patients compared to benign prostate disease patients (P = 0.623) and suggest that the number of CAGn was correlated with the relative expression of the AR gene (P = 0.009) and this correlation was positive, moderate, and proportional (ρ = 0.467) and no correlation was found between CAGn with other clinical features.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  • Albà M. M. and Guigó R. 2004 Comparative analysis of amino acid repeats in rodents and humans. Genome Res. 14, 549–554.

    Article  PubMed  PubMed Central  Google Scholar 

  • Álvarez-Castro P., Sangiao-Alvarellos S., Brandón-Sandá I. and Cordido F. 2011 Función endocrina en la obesidad. Endocrinol. Nutr. 58, 422–432.

    Article  PubMed  Google Scholar 

  • Aurilio G., Cimadamore A., Mazzucchelli R., Lopez-Beltran A., Verri E., Scarpelli M. et al. 2020 Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications. Cells 9, 2653.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Beilin J., Ball E., Favaloro J. and Zajac J. 2000 Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J. Mol. Endocrinol. 25, 85–96.

    Article  CAS  PubMed  Google Scholar 

  • Ben-Salem S. and Balaji Venkadakrishnan V. 2021 Novel insights in cell cycle dysregulation during prostate cancer progression. Endocr. Relat. Cancer 28, 141–155.

    Article  Google Scholar 

  • Buchanan G. 2004 Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum. Mol. Genet. 13, 1677–1692.

    Article  CAS  PubMed  Google Scholar 

  • Cai C., He H. H., Sen Chen, Coleman I., Wang H., Fang Z. et al. 2011 Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell 20, 457–471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Correa-Cerro L., Wöhr G., Häussler J., Berthon P., Drelon E., Mangin P. et al. 1999 (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population. Eur. J. Hum. Genet. 7, 357–362.

    Article  CAS  PubMed  Google Scholar 

  • Crumbaker M., Khoja L. and Joshua A. 2017 AR Signaling and the PI3K pathway in prostate cancer. Cancers 9, 34.

    Article  PubMed  PubMed Central  Google Scholar 

  • Davey R. A. and Grossmann M. 2016 Androgen receptor structure, function and biology: from bench to bedside. Clin. Biochem. Rev. 37, 3–15.

    PubMed  PubMed Central  Google Scholar 

  • Edwards S. M., Badzioch M. D., Minter R., Hamoudi R., Collins N., Ardern-Jones A. et al. 1999 Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int. J. Cancer 84, 458–465.

    Article  CAS  PubMed  Google Scholar 

  • Ellegren H. 2004 Microsatellites: simple sequences with complex evolution. Nat. Rev. Genet. 5, 435–445.

    Article  CAS  PubMed  Google Scholar 

  • Gómez R., Torres-Sánchez L., Camacho-Mejorado R., Burguete-García A. I., Vázquez-Salas R. A., Martínez-Nava G. A. et al. 2016 Androgen receptor CAG polymorphism and sporadic and early-onset prostate cancer among Mexican men. J. Hum. Genet. 61, 781–786.

    Article  PubMed  Google Scholar 

  • Gsur A., Preyer M., Haidinger G., Zidek T., Madersbacher S., Schatzl G. et al. 2002 Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis 23, 1647–1651.

    Article  CAS  PubMed  Google Scholar 

  • Gu M., Dong X., Zhang X. and Niu W. 2012 The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis. Mol. Biol. Rep. 39, 2615–2624.

    Article  CAS  PubMed  Google Scholar 

  • Gustincich S., Manfioletti G., Del Sal G., Schneider C. and Carninci P. 1991 A fast method for high-quality genomic DNA extraction from whole human blood. BioTechniques 11(298–300), 302.

    PubMed  Google Scholar 

  • Heinlein C. A. and Chang C. 2004 Androgen receptor in prostate cancer. Endocr. Rev. 25, 276–308.

    Article  CAS  PubMed  Google Scholar 

  • Hsing A. W., Gao Y. T., Wu G., Wang X., Deng J., Chen Y. L. et al. 2000 Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res. 60, 5111–5116.

    CAS  PubMed  Google Scholar 

  • Kim J. and Coetzee G. A. 2004 Prostate specific antigen gene regulation by androgen receptor. J. Cell. Biochem. 93, 233–241.

    Article  CAS  PubMed  Google Scholar 

  • Lindström S., Ma J., Altshuler D., Giovannucci E., Riboli E., Albanes D. et al. 2010 A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J. Clin. Endocrinol. Metab. 95, 121–127.

    Article  Google Scholar 

  • Livak K. J. and Schmittgen T. D. 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25, 402–408.

    Article  CAS  PubMed  Google Scholar 

  • Mitsis T., Efthimiadou A., Bacopoulou F., Vlachakis D., Chrousos G. and Eliopoulos E. 2020 Transcription factors and evolution: an integral part of gene expression (Review). World Acad. Sci. J. 2, 3–8.

    Google Scholar 

  • Nam R. K., Elhaji Y., Krahn M. D., Hakimi J., Ho M., Chu W. et al. 2000 Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression. J. Urol. 164, 567–572.

    Article  CAS  PubMed  Google Scholar 

  • Nelson K. A. and Witte J. S. 2002 Androgen receptor CAG repeats and prostate cancer. Am. J. Epidemiol. 155, 883–890.

    Article  PubMed  Google Scholar 

  • Nenonen H., Bjork C., Skjaerpe P. A., Giwercman A., Rylander L., Svartberg J. et al. 2010 CAG repeat number is not inversely associated with androgen receptor activity in vitro. Mol. Hum. Reprod. 16, 153–157.

    Article  CAS  PubMed  Google Scholar 

  • Pasquali R. 2006 Obesity and androgens: facts and perspectives. Fertil. Steril. 85, 1319–1340.

    Article  CAS  PubMed  Google Scholar 

  • Patiño-García B., Arroyo C., Rangel-Villalobos H., Soto-Vega E., Velarde-Félix J. S., Gabilondo F. et al. 2007 Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population. Rev. Investig. Clin. Organo Hosp. Enfermedades Nutr. 59, 25–31.

    Google Scholar 

  • Paz-Y-Miño C., Robles P., Salazar C., Leone P. E., García-Cárdenas J. M., Naranjo M. et al. 2016 Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer. Mol. Med. Rep. 14, 1791–1798.

    Article  PubMed  Google Scholar 

  • Price D. K., Chau C. H., Till C., Goodman P. J., Baum C. E. and Ockers S. B. 2010 Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial. J. Urol. 184, 2297–2302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun J. H. and Lee S. A. 2013 Association between CAG repeat polymorphisms and the risk of prostate cancer: a meta-analysis by race, study design and the number of (CAG)n repeat polymorphisms. Int. J. Mol. Med. 32, 1195–1203.

    Article  CAS  PubMed  Google Scholar 

  • Taylor S. C., Nadeau K., Abbasi M., Lachance C., Nguyen M. and Fenrich J. 2019 The ultimate qPCR experiment: producing publication quality, reproducible data the first time. Trends Biotechnol. 37, 761–774.

    Article  CAS  PubMed  Google Scholar 

  • Urbanucci A., Waltering K. K., Mills I. G. and Visakorpi T. 2013 The effect of AR overexpression on androgen signaling in prostate cancer. In Androgen-responsive genes in prostate cancer (ed. Z. Wang), Springer, New York, pp. 187–200..

    Chapter  Google Scholar 

  • Xu J., Meyers D. A., Sterling D. A., Zheng S. L., Catalona W. J., Cramer S. D. et al. 2002 Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 11, 664–669.

    CAS  Google Scholar 

  • Xue W. M., Coetzee G. A., Ross R. K., Irvine R., Kolonel L. and Henderson B. E. 2001 Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored. Am. Soc. Prev. Oncol. 10, 575–579.

    CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Universidad Autónoma de Sinaloa and the Universidad Politécnica de Sinaloa. We thank Fernando Coronado Nieves and Yolanda Galvez Vazquez for their help during the collection of samples, as well as Andrea Ross Orozco, for her help during the experiments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noemi García Magallanes.

Additional information

Corresponding editor: Durgadas P. Kasbekar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Irigoyen Arredondo, M., Romero Quintana, J., Arámbula Meraz, E. et al. Differential expression of the androgen receptor gene is correlated with CAG polymorphic repeats in patients with prostate cancer. J Genet 102, 23 (2023). https://doi.org/10.1007/s12041-023-01421-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12041-023-01421-1

Keywords

Navigation